Japan Artificial Intelligence In Cancer Diagnostics Market Size & Outlook
Related Markets
Japan artificial intelligence in cancer diagnostics market highlights
- The Japan artificial intelligence in cancer diagnostics market generated a revenue of USD 8.4 million in 2023 and is expected to reach USD 51.2 million by 2030.
- The Japan market is expected to grow at a CAGR of 29.4% from 2024 to 2030.
- In terms of segment, software was the largest revenue generating component type in 2023.
- Services is the most lucrative component type segment registering the fastest growth during the forecast period.
Artificial intelligence in cancer diagnostics market data book summary
| Market revenue in 2023 | USD 8.4 million |
| Market revenue in 2030 | USD 51.2 million |
| Growth rate | 29.4% (CAGR from 2023 to 2030) |
| Largest segment | Software |
| Fastest growing segment | Services |
| Historical data | 2018 - 2022 |
| Base year | 2023 |
| Forecast period | 2024 - 2030 |
| Quantitative units | Revenue in USD million |
| Market segmentation | Software, Hardware, Services |
| Key market players worldwide | Microsoft Corp, Roche Holding AG, Quest Diagnostics Inc, Medial EarlySign, CancerCenter.AI, Therapixel, Tempus, Kheiron, SkinVision |
Other key industry trends
- In terms of revenue, Japan accounted for 4.3% of the global artificial intelligence in cancer diagnostics market in 2023.
- Country-wise, U.S. is expected to lead the global market in terms of revenue in 2030.
- In Asia Pacific, China artificial intelligence in cancer diagnostics market is projected to lead the regional market in terms of revenue in 2030.
- Australia is the fastest growing regional market in Asia Pacific and is projected to reach USD 10.8 million by 2030.
No credit card required*
Horizon in a snapshot
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
Artificial Intelligence In Cancer Diagnostics Market Scope
Artificial Intelligence In Cancer Diagnostics Market Companies
| Name | Profile | # Employees | HQ | Website |
|---|---|---|---|---|
| SkinVision | View profile | 11-50 | Amsterdam, Noord-Holland, The Netherlands, Europe | https://skinvision.com |
| Kheiron | View profile | 11-50 | London, England, United Kingdom, Europe | https://www.kheironmed.com/ |
| Tempus | View profile | 501-1000 | Chicago, Illinois, United States, North America | https://www.tempus.com |
| Therapixel | View profile | 11-50 | Nice, Provence-Alpes-Cote d'Azur, France, Europe | http://www.therapixel.com/ |
| CancerCenter.AI | View profile | 11-50 | Wroclaw, Dolnoslaskie, Poland, Europe | https://cancercenter.ai |
| Medial EarlySign | View profile | 11-50 | Hod Hasharon, HaMerkaz, Israel, Asia | http://earlysign.com/ |
| Quest Diagnostics Inc | View profile | 48000 | 500 Plaza Drive, Secaucus, NJ, United States, 07094 | https://www.questdiagnostics.com |
| Roche Holding AG | View profile | 103605 | Grenzacherstrasse 124, Basel, Switzerland, 4070 | https://www.roche.com |
| Microsoft Corp | View profile | 221000 | One Microsoft Way, Redmond, WA, United States, 98052-6399 | https://www.microsoft.com |
Japan artificial intelligence in cancer diagnostics market outlook
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to artificial intelligence in cancer diagnostics market will help companies and investors design strategic landscapes.
Software was the largest segment with a revenue share of 48.81% in 2024. Horizon Databook has segmented the Japan artificial intelligence in cancer diagnostics market based on software, hardware, services covering the revenue growth of each sub-segment from 2018 to 2030.
Japan is embracing AI in many forms and the government is expected to invest around USD 100 billion in the coming 5 years to construct hospitals that are backed by AI. According to Healthcare Asia, the Japanese government is expected to establish 10 AI-based hospitals in the coming years, which will help address concerns such as a shortage of medical personnel and rising medical expenses.
Thus, the government is making significant investments in AI technologies, as it is considered an essential driver of future competitiveness. Growing awareness about advanced technologies is expected to boost usage of AI in diagnostics.
For instance, in July 2018, two Japanese research institutes succeeded in incorporating AI solutions for diagnosing early-stage stomach cancer at a high precision rate of 95% for healthy tissues and 80% for cancer tissues. According to National Cancer Centre and Riken, AI solutions take 0.004 seconds to analyze whether an obtained endoscopic image contains normal stomach tissue or early-stage cancer tissue.
Reasons to subscribe to Japan artificial intelligence in cancer diagnostics market databook:
-
Access to comprehensive data: Horizon Databook provides over 1 million market statistics and 20,000+ reports, offering extensive coverage across various industries and regions.
-
Informed decision making: Subscribers gain insights into market trends, customer preferences, and competitor strategies, empowering informed business decisions.
-
Cost-Effective solution: It's recognized as the world's most cost-effective market research database, offering high ROI through its vast repository of data and reports.
-
Customizable reports: Tailored reports and analytics allow companies to drill down into specific markets, demographics, or product segments, adapting to unique business needs.
-
Strategic advantage: By staying updated with the latest market intelligence, companies can stay ahead of competitors, anticipate industry shifts, and capitalize on emerging opportunities.
Target buyers of Japan artificial intelligence in cancer diagnostics market databook
-
Our clientele includes a mix of artificial intelligence in cancer diagnostics market companies, investment firms, advisory firms & academic institutions.
-
30% of our revenue is generated working with investment firms and helping them identify viable opportunity areas.
-
Approximately 65% of our revenue is generated working with competitive intelligence & market intelligence teams of market participants (manufacturers, service providers, etc.).
-
The rest of the revenue is generated working with academic and research not-for-profit institutes. We do our bit of pro-bono by working with these institutions at subsidized rates.
Horizon Databook provides a detailed overview of country-level data and insights on the Japan artificial intelligence in cancer diagnostics market , including forecasts for subscribers. This country databook contains high-level insights into Japan artificial intelligence in cancer diagnostics market from 2018 to 2030, including revenue numbers, major trends, and company profiles.
Partial client list
Japan artificial intelligence in cancer diagnostics market size, by component type, 2018-2030 (US$M)
Japan Artificial Intelligence In Cancer Diagnostics Market Outlook Share, 2024 & 2030 (US$M)
Related statistics
Sign up - it's easy, and free!
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
